title: Dietary linoleic acid intake controls the arterial blood plasma concentration and the rates of growth and linoleic acid uptake and metabolism in hepatoma 7288CTC in Buffalo rats.
abstract: In this study, we tested the hypothesis that dietary linoleic acid intake controls the arterial blood plasma linoleic acid concentration and the rates of tumor growth and linoleic acid metabolism in vivo. Seven groups of young male Buffalo rats (11-21 rats/group) were given free access to semipurified diets containing different amounts of corn and/or olive oils. Four other groups (7-11 rats/group) were 30% energy-restricted. Each experiment included periods for rat growth and plasma lipid stabilization (6 wk), measurement of mean daily arterial blood plasma fatty acid concentrations (3 wk), surgical implantation of a subcutaneous tissue-isolated hepatoma 7288CTC, tumor growth and harvest (2-4 wk). Linoleic + arachidonic acid (P = 0.007) and oleic acid (P = 0.002) concentrations in arterial blood plasma were increased as dietary intake of linoleic and oleic acids was increased, respectively. In rats given free access to food, tumor growth was directly dependent on the plasma concentrations of linoleic (P < 0.001) and arachidonic acids (P = 0.04). Tumor growth in energy-restricted rats was dependent only on the linoleic acid concentration (P = 0.008). Energy restriction itself caused a growth inhibition independent of plasma linoleic acid. The linoleic acid and total fatty acid concentrations of tumor triacylglycerols were directly dependent on the plasma linoleic acid concentration in rats given free access to food (P = 0.009). Hepatoma 7288CTC (both in vivo and during perfusion in situ) supported a dose-dependent conversion (P < 0.001) of plasma linoleic acid to the mitogen, 13-hydroxy-9, 11-octadecadienoic acid. We conclude that increased arterial blood plasma linoleic acid concentrations, caused by increased dietary intakes, specifically stimulate growth, lipid storage and linoleic acid metabolism in hepatoma 7288CTC in vivo.
authors.affiliation: Research Institute, Bassett Healthcare, Cooperstown, NY 13326, USA.
authors.forename: L A
authors.initials: LA
authors.lastname: Sauer
authors.forename: R T
authors.initials: RT
authors.lastname: Dauchy
authors.forename: D E
authors.initials: DE
authors.lastname: Blask
mesh_terms: D000818:Animals; D016718:Arachidonic Acid / Q000097:blood / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D002250:Carbon Radioisotopes; D002455:Cell Division / Q000187:drug effects; D002940:Circadian Rhythm / Q000502:physiology; D004041:Dietary Fats / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005227:Fatty Acids / Q000032:analysis / Q000097:blood; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology*; D008055:Lipids / Q000097:blood; D008114:Liver Neoplasms, Experimental / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051381:Rats; D011915:Rats, Inbred BUF; D014280:Triglycerides / Q000032:analysis / Q000097:blood
chemical_list: D002250:Carbon Radioisotopes; D004041:Dietary Fats; D005227:Fatty Acids; D008041:Linoleic Acids; D008055:Lipids; D014280:Triglycerides; D016718:Arachidonic Acid; D019787:Linoleic Acid